Krishna Kannan, PhD

Senior Director, Product Development at Telesis Bio

Speaker

Dr. Krishna Kannan is the Senior Director of Product Development at Telesis Bio. He received his PhD from the University of Illinois at Chicago. He is a long-time associate of Dr. Dan Gibson– the creator of the Gibson assembly® method and has worked closely with other Synthetic Biology pioneers at the J Craig Venture Institute and Viridos (formerly Synthetic Genomics), contributing to the development of the first synthetic cell with a minimal genome and the digital-to-biological converter. Dr. Kannan is widely published in leading peer-reviewed publications such as Cell, Science and Nature Biotechnology. Most recently he has been instrumental in synthetic biology workflow innovations at Telesis Bio including the first de novo full-length construction of the SARS-CoV-2 genome and the novel digital sequence-to-mRNA synthesis automation workflow. Dr. Kannan’s team has also been critically involved in the introduction of the next-generation of Telesis Bio’s automated synthetic biology workstation, the BioXp 9600.